OLEMA PHARMACEUTICALS INC's ticker is OLMA and the CUSIP is 68062P106. A total of 113 filers reported holding OLEMA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $331,005 | +18.8% | 30,592 | +54.0% | 0.01% | -22.2% |
| Q4 2023 | $278,720 | +124.8% | 19,866 | -34.9% | 0.01% | +80.0% |
| Q2 2022 | $124,000 | -24.4% | 30,533 | -20.7% | 0.01% | -28.6% |
| Q1 2022 | $164,000 | +23.3% | 38,500 | +171.9% | 0.01% | -12.5% |
| Q4 2021 | $133,000 | – | 14,162 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 2,654,867 | $28,725,661 | 4.46% |
| Paradigm Biocapital Advisors LP | 7,903,600 | $85,516,952 | 3.27% |
| Logos Global Management LP | 3,208,875 | $34,720,028 | 2.82% |
| BVF INC/IL | 9,135,893 | $98,850,362 | 2.77% |
| Vivo Capital, LLC | 1,873,704 | $20,273,477 | 1.87% |
| Ghost Tree Capital, LLC | 550,000 | $5,951,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 796,880 | $8,622,242 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 546,863 | $5,917,058 | 1.40% |
| Deep Track Capital, LP | 4,000,000 | $43,280,000 | 1.29% |
| HighVista Strategies LLC | 247,880 | $2,682,062 | 0.98% |